Algernon Pharmaceuticals Inc (AGNPF)

[Money $hot]

Well...Well...Well. What Do We Have Here?

We have a "pure comparison" to Algernon's DMT angle for Ischemic Stroke.

Ninnion is a start up psychedelics biotech company established as recent as November 2020.

A read of their news release and website narrative for Ischemic Stroke is damn near the same script as Algernon.

https://newsdirect.com/news/psychedelic-pharmaceutical-startup-ninnion-announces-patent-filings-and-development-of-nin-s119-for-ischemic-stroke-796315381

As of now Ninnion plans a Phase 1 Ischemic Stroke clinical trial in Q1 2023. It will be a sure fire comparison to how they execute their timelines to data readouts at each stage.

Anyone willing to place a bet Ninnion will likely run circles around Algernon's timelines just as Bellus Health dors with Chronic Cough?

My guess is Ninnion will run clinical trials in good ole USA versus searching for cover high and low in any country other than North America.

Surely, there will be those laying claim and calling foul because Ninnion appears to be a private company. So what, it doesn't change the timeline comparison one iota.

Shout out to PretEnders @ stocktwits for the Due Diligence scoop.

Ninnion website: https://ninnion.com/aboutus/

There's a saying about it not being about how you start, but rather how you finish. In Algernon's case history, Algernon starts weak and finishes even weaker.

Happy Tuesday (Q2 2022),

M$